Pharming Group N.V. (PHAR)
NASDAQ: PHAR · Real-Time Price · USD
16.42
-0.50 (-2.96%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Pharming Group Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
1,1721,147650763756572
Upgrade
Market Cap Growth
113.32%76.58%-14.84%0.93%32.18%-42.41%
Upgrade
Enterprise Value
1,1091,112608728702554
Upgrade
Last Close Price
16.4217.6710.0611.4311.038.94
Upgrade
PE Ratio
411.03402.37--55.2735.75
Upgrade
PS Ratio
3.123.052.193.113.682.88
Upgrade
PB Ratio
4.234.142.943.493.692.96
Upgrade
P/TBV Ratio
8.288.104.065.175.825.23
Upgrade
P/FCF Ratio
21.7221.26--35.8521.10
Upgrade
P/OCF Ratio
21.4220.97--33.6615.11
Upgrade
EV/Sales Ratio
2.952.962.052.973.412.78
Upgrade
EV/EBITDA Ratio
27.9928.07188.69-40.9718.22
Upgrade
EV/EBIT Ratio
33.8533.94--67.7023.07
Upgrade
EV/FCF Ratio
20.5520.61--33.2920.43
Upgrade
Debt / Equity Ratio
0.420.420.510.780.820.84
Upgrade
Debt / EBITDA Ratio
2.692.6917.02-8.464.88
Upgrade
Debt / FCF Ratio
2.152.15--7.915.97
Upgrade
Net Debt / Equity Ratio
-0.23-0.23-0.25-0.19-0.20-0.16
Upgrade
Net Debt / EBITDA Ratio
-1.60-1.60-17.242.74-2.37-0.99
Upgrade
Net Debt / FCF Ratio
-1.17-1.1721.502.24-1.93-1.11
Upgrade
Asset Turnover
0.840.840.690.550.500.49
Upgrade
Inventory Turnover
0.750.750.630.510.500.87
Upgrade
Quick Ratio
1.971.972.963.283.904.69
Upgrade
Current Ratio
2.592.593.774.064.655.33
Upgrade
Return on Equity (ROE)
1.02%1.02%-5.38%-4.98%6.88%8.50%
Upgrade
Return on Assets (ROA)
4.55%4.55%-0.52%-3.06%1.57%3.68%
Upgrade
Return on Invested Capital (ROIC)
2.92%3.41%-2.10%-12.76%5.79%10.98%
Upgrade
Return on Capital Employed (ROCE)
8.50%8.50%-1.10%-5.70%2.80%6.80%
Upgrade
Earnings Yield
0.24%0.25%-1.82%-1.38%1.81%2.80%
Upgrade
FCF Yield
4.60%4.70%-0.40%-2.46%2.79%4.74%
Upgrade
Buyback Yield / Dilution
-11.25%-11.25%-2.18%7.09%-0.85%-2.70%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.